Catalyst Wire Dossier Catalyst Wire Dossier

Monovalent glycoprotein-conjugated Hib vaccine (Diphtheria Toxin-CRM197)

· Novartis Vaccines
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Monovalent glycoprotein-conjugated Hib vaccine (Diphtheria Toxin-CRM197), covering 2011-12-30 to 2011-12-30. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Safety of a Booster Dose of Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 365-569 Days Old Healthy Infants [Phase 3]

See pricing